A Phase 1/2 Dose Escalation Study to Evaluate the Safety and Efficacy of SR-02 Pancreatic Endocrine Cell Clusters Implanted in the Omentum of Adults With Type 1 Diabetes (SUGR)

Seraxis0 个研究点目标入组 9 人开始时间: 2026年11月1日最近更新: 2026年5月12日

试验速览

阶段: 1 期
状态: 尚未招募
发起方
入组人数: 9

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe recurrent hypoglycemia. The study will also help establish the optimal treatment dose. Although this study is open to patients with all HLA or blood types, immunosuppression to prevent rejection will be required in this first in human study.

研究设计

研究类型: Interventional
分配方式: Na
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 65 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Adult 18 to 65 years with a clinical history of T1D
•Diagnosis of T1D at <40 years of age
•Insulin dependence for ≥5 years at pre-screening
•Recurrent severe hypoglycemia
•Willingness to use continuous glucose monitoring

排除标准

•Use of anti-diabetic agent other than insulin(s) or insulin analog(s) within 3 months of Screening
•Weight loss medication(s) within 3 months of Screening
•Other protocol defined Inclusion/Exclusion criteria may apply.

研究者

发起方

Seraxis

申办方类型

Industry

责任方

Sponsor

相似试验

招募中

2 期

A Phase 1b/2 Study of the Combination of Talquetamab and Teclistamab in Participants with Relapsed or Refractory Multiple MyelomaMultiple Myeloma

2023-503439-16-00Janssen - Cilag International51

招募中

1 期

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate CancerMetastatic Prostate Cancer

NCT07529717AstraZeneca42

尚未招募

2 期

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

NCT07487519Shanghai Henlius Biotech180

招募中

1 期

Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC

NCT07355972Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12

招募中

1 期

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

NCT07278479Molecular Partners AG138